U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented to overcome listed industry challenges. This research service does not include market revenue forecasts for DMARDs. This research service highlights product forecasts for biologic products as well as small molecules near launch.

Table of Contents

U.S. Rheumatoid Arthritis Market, U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New TreatmentsAnalysis of the U.S. Rheumatoid Arthritis MarketResearch Service

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.